118 related articles for article (PubMed ID: 22025137)
1. Population-based study of breast cancer screening in Côte d'Or (France): clinical implications and factors affecting screening round adequacy.
Ouedraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
Eur J Cancer Prev; 2011 Nov; 20(6):462-74. PubMed ID: 22025137
[TBL] [Abstract][Full Text] [Related]
2. Attending breast cancer screening alone does not explain the detection of tumours at an early stage.
Ouédraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
Eur J Cancer Prev; 2013 Mar; 22(2):103-11. PubMed ID: 22751208
[TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
4. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
[TBL] [Abstract][Full Text] [Related]
5. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
6. [Cancer of the breast in Cote-d'Or (1982-1987). The Burgundian register of gynecologic diseases].
Chaplain G; Cuisenier J; Le Dorze C; Pansiot F; Bastien H
Bull Cancer; 1990; 77(1):5-14. PubMed ID: 2317576
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer screening in women aged 50-74 years: is there room for improvement?
Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F
Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683
[TBL] [Abstract][Full Text] [Related]
8. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
9. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
10. Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases.
Seigneurin A; Exbrayat C; Labarère J; Delafosse P; Poncet F; Colonna M
Breast Cancer Res Treat; 2011 May; 127(1):221-8. PubMed ID: 20809364
[TBL] [Abstract][Full Text] [Related]
11. [French screening program of breast cancer. Results from 5 districts (1989-1994)].
Séradour B; Allemand H; Schaffer P
Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188
[TBL] [Abstract][Full Text] [Related]
12. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
[TBL] [Abstract][Full Text] [Related]
13. [Breast self-examination also valuable in women participating in a screening programme].
Zonderhuis BM; Meijer S; Been J; Groot JJ; Langenhorst F; van den Tol MP
Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2341-5. PubMed ID: 19024066
[TBL] [Abstract][Full Text] [Related]
14. Detection method and breast carcinoma histology.
Newcomer LM; Newcomb PA; Trentham-Dietz A; Storer BE; Yasui Y; Daling JR; Potter JD
Cancer; 2002 Aug; 95(3):470-7. PubMed ID: 12209738
[TBL] [Abstract][Full Text] [Related]
15. Mode of breast cancer detection: a study from the German part of the Maas-Rhine-EUREGIO.
Schleicher UM; Ammon J
Eur J Cancer Prev; 1998 Feb; 7 Suppl 1():S41-6. PubMed ID: 10866035
[TBL] [Abstract][Full Text] [Related]
16. Attending the breast screening programme after breast cancer treatment: a population-based study.
de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
[TBL] [Abstract][Full Text] [Related]
17. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or].
Coudert B; Chaplain G; Milan C; Janoray P
Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857
[TBL] [Abstract][Full Text] [Related]
18. Potential impact of USPSTF recommendations on early diagnosis of breast cancer.
Aragon R; Morgan J; Wong JH; Lum S
Ann Surg Oncol; 2011 Oct; 18(11):3137-42. PubMed ID: 21947591
[TBL] [Abstract][Full Text] [Related]
19. Associations in breast and colon cancer screening behavior in women.
Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
[TBL] [Abstract][Full Text] [Related]
20. [Using medical imaging for a comprehensive breast cancer screening program].
Dilhuydy MH
Bull Cancer; 2009 Nov; 96(11):1071-86. PubMed ID: 19887333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
